HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.69
Day range
$0.67 - $0.69
Year range
$0.54 - $1.14
Market cap
62.57M CAD
Avg Volume
31.65K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.47M | 14.09% |
Net income | -1.46M | -17.20% |
Net profit margin | — | — |
Earnings per share | -0.02 | 0.00% |
EBITDA | -1.42M | -12.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 983.00K | -61.04% |
Total assets | 2.65M | -26.78% |
Total liabilities | 1.19M | 73.32% |
Total equity | 1.46M | — |
Shares outstanding | 90.68M | — |
Price to book | 34.50 | — |
Return on assets | -133.03% | — |
Return on capital | -232.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.46M | -17.20% |
Cash from operations | -1.28M | -56.97% |
Cash from investing | -12.00K | 96.01% |
Cash from financing | 1.06M | -15.65% |
Net change in cash | -245.00K | -277.54% |
Free cash flow | -315.25K | 64.86% |
About
Founded
2011
Website
Employees
9
